BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2014493)

  • 1. Effect of terbutaline on bronchoconstriction induced by nebulised pentamidine.
    Leigh TR; Wiggins J; Gazzard BG; Collins JV
    Thorax; 1991 Feb; 46(2):122-3. PubMed ID: 2014493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of several agents with two delivery systems for the prevention of airway narrowing induced by nebulised pentamidine isethionate.
    Leigh TR; Wiggins J; Gazzard B; Collins JV
    Respir Med; 1991 Nov; 85(6):527-31. PubMed ID: 1663642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol pentamidine-induced bronchoconstriction. Predictive factors and preventive therapy.
    Quieffin J; Hunter J; Schechter MT; Lawson L; Ruedy J; Paré P; Montaner JS
    Chest; 1991 Sep; 100(3):624-7. PubMed ID: 1832372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
    Miller RF; Godfrey-Faussett P; Semple SJ
    Thorax; 1989 Jul; 44(7):565-9. PubMed ID: 2788936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung deposition of nebulised pentamidine in children.
    O'Doherty MJ; Thomas SH; Gibb D; Page CJ; Harrington C; Duggan C; Nunan TO; Bateman NT
    Thorax; 1993 Mar; 48(3):220-6. PubMed ID: 8497819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient tolerance of nebulized pentamidine or cotrimoxazole as secondary prophylaxis for Pneumocystis carinii pneumonia.
    Smith DE; Hills DA; Gazzard BG
    AIDS; 1992 Sep; 6(9):1044-5. PubMed ID: 1388897
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill.
    O'Doherty M; Thomas S; Page C; Bradbeer C; Nunan T; Bateman N
    Thorax; 1990 Jun; 45(6):460-4. PubMed ID: 2392791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of preservative on the efficacy of terbutaline nebuliser solution in atopic asthma.
    Lai CK; Chan CH
    Thorax; 1993 May; 48(5):566-8. PubMed ID: 8322247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of aerosolized pentamidine-induced bronchospasm: a symptom-based approach.
    McSharry RJ; Kirsch CM; Jensen WA; Kagawa FT
    Am J Med Sci; 1993 Jul; 306(1):20-2. PubMed ID: 8328505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentamidine.
    Gazzard B
    Br J Clin Pract; 1989 May; 43(5):153-7. PubMed ID: 2686746
    [No Abstract]   [Full Text] [Related]  

  • 11. A dose-response study of inhaled terbutaline administered via Nebuhaler or nebuliser to asthmatic children.
    Blackhall MI; O'Donnell SR
    Eur J Respir Dis; 1987 Aug; 71(2):96-101. PubMed ID: 3622669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers.
    Thomas SH; O'Doherty MJ; Page CJ; Nunan TO; Bateman NT
    Eur Respir J; 1991 May; 4(5):616-22. PubMed ID: 1936233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer.
    Murphy RL; Lavelle JP; Allan JD; Gordin FM; Dupliss R; Boswell SL; Waskin HA; Davies SF; Graziano FM; Saag MS
    Am J Med; 1991 Apr; 90(4):418-26. PubMed ID: 2012082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rash due to nebulised pentamidine.
    Leen CL; Mandal BK
    Lancet; 1988 Nov; 2(8622):1250-1. PubMed ID: 2903979
    [No Abstract]   [Full Text] [Related]  

  • 15. Bronchial responsiveness in AIDS patients with Pneumocystis carinii pneumonia.
    Ong EL; Hanley SP; Mandal BK
    AIDS; 1992 Nov; 6(11):1331-3. PubMed ID: 1472337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methacholine challenge tests to demonstrate therapeutic equivalence of terbutaline sulfate via different Turbuhaler
    Bjermer L; Gauvreau GM; Postma DS; O'Byrne PM; van den Berge M; Boulet LP; Beckman O; Persson T; Román J; Carlholm M; Schützer KM; Eckerwall G
    Pulm Pharmacol Ther; 2017 Jun; 44():1-6. PubMed ID: 28232118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in relative efficiency of nebulisers for pentamidine administration.
    O'Doherty MJ; Thomas S; Page C; Barlow D; Bradbeer C; Nunan TO; Bateman NT
    Lancet; 1988 Dec; 2(8623):1283-6. PubMed ID: 2904008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD).
    Poole PJ; Brodie SM; Stewart JM; Black PN
    Aust N Z J Med; 1998 Jun; 28(3):322-6. PubMed ID: 9673744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalatory pentamidine therapy and the duration of the QT interval in HIV-infected patients.
    Cardoso JS; Mota-Miranda A; Conde C; Moura B; Rocha-Gonçalves F; Lecour H
    Int J Cardiol; 1997 May; 59(3):285-9. PubMed ID: 9183045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical bronchoconstriction with nebulized albuterol but not with terbutaline.
    Finnerty JP; Howarth PH
    Am Rev Respir Dis; 1993 Aug; 148(2):512-3. PubMed ID: 8342917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.